Institutional Ownership Lyell Immunopharma, Inc. (LYEL)
This table provides information about the institutional ownership of Lyell Immunopharma, Inc. (LYEL). We have compiled data on the 9 institutions that hold shares in the stock, with a total of 37.4 Million shares, which have been reported (via 13F filing form) to have a value of $633 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Apoletto LTD
Washington, DC |
Nov 14, 2022 Q3 2022 |
15,093,969
shares
|
$256 Million
42.56% of portfolio
|
Q4 2021
Reduced 0.49%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,495,132
shares
|
$228 Million
0.0% of portfolio
|
Q2 2024
Reduced 2.86%
|
|
|
Wu Xi App Tec Co., Ltd.
Shanghai, F4 |
Nov 08, 2024 Q3 2024 |
7,390,710
shares
|
$125 Million
53.56% of portfolio
|
Q3 2024
Reduced 3.79%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
641,173
shares
|
$10.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 25.14%
|
|
|
Decheng Capital LLC
Menlo Park, CA |
Nov 14, 2025 Q3 2025 |
595,466
shares
|
$10.1 Million
1.69% of portfolio
|
Q2 2025
Reduced 95.0%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
123,256
shares
|
$2.09 Million
0.0% of portfolio
|
Q1 2024
Added 6.05%
|
|
|
Sawtooth Solutions, LLC
|
Jan 29, 2024 Q4 2023 |
48,108
shares
|
$814,468
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Vista Wealth Management Group, LLC
|
Apr 17, 2025 Q1 2025 |
13,043
shares
|
$220,817
0.0% of portfolio
|
Q4 2024
Reduced 37.5%
|
|
|
Sargent Bickham Lagudis LLC
|
Jan 23, 2023 Q4 2022 |
1,000
shares
|
$16,930
0.0% of portfolio
|
Q4 2022
New holding
|